Custom content for TD2 by studioID

The Future of Oncology:​ A Better Way to Research Cancer Treatments

Being overweight or obese is a significant comorbidity of cancer: it’s associated with an increased risk of 13 types of cancer that, combined, comprise about 40% of all cancers diagnosed in the United States. 

Given that 75% of all Americans are categorized as overweight or obese, this statistic is sobering. And yet most cancer research is still using mice that were developed nearly a century ago, when the national obesity rate was in the single digits. In this playbook, we explore the diet induced obesity tumor model, a potentially superior approach to cancer research that better reflects the current population. After reading it, you’ll understand:

  • What the diet induced obesity tumor models is
  • How metabolomics was used to establish and validate this model
  • How metabolomics can be used downstream on any cancer study to determine if a cancer drug trial is working


GET THE PLAYBOOK

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2023 Industry Dive | Privacy Policy | Terms of Use